Verala Med
ActiveVerala Med has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €451k and a net result of €221k. Equity is growing by ~84.7% per year across the filed fiscal years. Its solvency ranks better than 81% of 7740 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record82
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days only on tighter terms
Liquidity ample (current ratio 5.51 against 4.6 in 2024; short-term debt: 18.1% and cash: 7.9% of total assets), and 18.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Sector 82
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
81.9%
Return on assets
40%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
1 d early
2024
on the day
2023
on the day
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€451k▲ 95.7%
2024 · €230k
2023: €60k
2024: €230k
2023 → 2025
Total assets
€551k▲ 86.9%
2024 · €295k
2023: €89k
2024: €295k
2023 → 2025
Net result
€221k▲ 29.8%
2024 · €170k
2023: €58k
2024: €170k
2023 → 2025
Working capital
€449k▲ 94.6%
2024 · €231k
2023: €60k
2024: €231k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€60k-€230k▲ 281%€451k▲ 95.7%
Operating result€80k-€249k▲ 212%€319k▲ 28.4%
Net result€58k-€170k▲ 193%€221k▲ 29.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 28% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €551k
Fixed assets
€2k
Current assets
€548k
Equity and liabilities €551k
Equity
€451k▲ 95.7%
Debt
€100k▲ 55.2%
The debt ratio falls from 21.8% to 18.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€319k
Cash flow
€221k
Solvency
81.9%▲
2024 · 78.2%
Current ratio
5.51▲
2024 · 4.60
Quick ratio
5.51▲
2024 · 4.60
Debt / equity
0.22▼
2024 · 0.28
ROE
48.9%▼
2024 · 73.7%
ROA
40.0%▼
2024 · 57.7%
Interest coverage
818.66
Debt
€100k▲
2024 · €64k
Debt ≤ 1 year
€99k▲
2024 · €64k
Income taxes
€102k▲
2024 · €79k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€295k€551k▲
Fixed assets21/28-€2k
Tangible fixed assets22/27-€2k
Furniture and vehicles24-€2k
Current assets29/58€295k€548k▲
Amounts receivable within one year40/41€528€13k▲
Trade receivables40€528€13k▲
Current investments50/53€271k€492k▲
Cash at bank and in hand54/58€24k€43k▲
Equity and liabilities
Total equity and liabilities10/49€295k€551k▲
Equity10/15€230k€451k▲
Contributions10/11€3k€3k=
Reserves13€228k€448k▲
Distributable reserves133€228k€448k▲
Amounts payable17/49€64k€100k▲
Amounts payable within one year42/48€64k€99k▲
Trade debts44€1€500▲
Suppliers440/4€1€500▲
Taxes, remuneration and social security45€64k€99k▲
Taxes450/3€61k€93k▲
Remuneration and social security454/9€3k€6k▲
Accrued charges and deferred income492/3€239€320▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€146
Other operating charges640/8-€144
Gross operating margin9900€249k€320k▲
Operating profit (loss)9901€249k€319k▲
Financial income75/76B€730€4k▲
Recurring financial income75€730€4k▲
Financial charges65/66B€279€390▲
Recurring financial charges65€279€390▲
Profit (loss) for the period before taxes9903€249k€323k▲
Income taxes67/77€79k€102k▲
Profit (loss) for the period9904€170k€221k▲
Profit (loss) for the period to be appropriated9905€170k€221k▲
Appropriation of the result
Profit (loss) to be appropriated9906€170k€221k▲
Transfer to equity691/2€170k€221k▲
To other reserves6921€170k€221k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €221k ▲29.8%
Operating result €319k, net result €221k, both a record.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200kEq €230k ▲281%
2 profitable years in a row build equity to €230k.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Fortlaan 439000 GentGround area
215 m²
Building footprint
105 m²
Volume, LiDAR
939 m³
Parcel 44808H0014/00P002, Flanders · tallest building 26.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Verala Med
since 20232.350.768.967
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44808H0014/00P002 | Flanders | 215 m² | 1 · 105 m² | 26.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Confédération Européenne de l'Industrie de la Chaussure
BE 0864.172.901
Brussel · Eq €451k
JAPO
BE 0681.592.373
Antwerpen · Eq €451k
T-MOL
BE 0800.686.203
Genk · Eq €451k
COMPACCO
BE 0896.217.048
Zedelgem · Eq €451k
VIU
BE 0558.844.912
Halle · Eq €452k
Of 24,503 companies in sector 82990 we hold annual accounts for 9,402. 6,015 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-10-2023
Fiscal year end31-12
Activities, NACEBEL
82990Other business support services
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.